Immunovant, Inc. (IMVT)
$43.32-2.37%Close
BUYBULL · day 12
Key stats
- Market cap
- $8.9B
- Avg volume
- 1.6M
- Beta
- 0.81
- P/E (TTM)
- -15.36
- 1W
- -0.89%
- 1M
- +9.92%
- 3M
- +26.85%
- YTD
- +67.19%
- vs SPY 1W
- +0.30%
- vs SPY 1M
- +6.60%
- vs SPY 3M
- +24.46%
- vs SPY YTD
- +55.44%
Industry peers
FMP comparable companies · ranked by market cap
- PRAXBUYPraxis Precision Medicines, Inc.$10.2BBULLQ 14$364.58-2.10%
- KYMRBUYKymera Therapeutics, Inc.$10.0BBULLQ 27$121.50+1.04%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.69+0.11%
- ACADBUYACADIA Pharmaceuticals Inc.$5.0BBULLQ 19$29.04+0.51%
- DYNBUYDyne Therapeutics, Inc.$4.9BBULLQ 8$25.98-0.42%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- VKTXSELLViking Therapeutics, Inc.$4.0BRECOVERYQ 23$34.36-1.95%
- NAMSSELLNewAmsterdam Pharma Company N.V.$3.2BRECOVERYQ 29$27.78-3.66%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- RARESELLUltragenyx Pharmaceutical Inc.$2.5BRECOVERYQ -1$25.32-0.43%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 12
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-41.8%
REV YoY-
ROE-11.2%
EPS YoY-
ROA-63.1%
GROSS97
OP-7877
NET-7586
[VALUATION]
P/E TTM-15.36
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B12.11
P/FCF-
EV/EBITDA-15.12
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO7.27
ND/EBITDA-
BETA0.81
NET INCOME (TTM) < 0
